-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Aston Villa Defy History With Rare Victory at Old Trafford
-
Brussels Education Unions Schedule Major November Protest Over Funding and Reforms
-
Crowds Gather at San Francisco Park for Elizabeth Holmes Lookalike Tournament
-
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
-
Releaf Unveils UK-first THCV for Weight Management
-
Gabriel Provides Corporate Update
-
AsiaFIN's Insite MY Holdings and MENA Insite MY Sign Distributorship Agreement and Announce Second Bank Customer in Saudi Arabia
-
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
-
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
-
Nextech3D.ai Closes $720,000 Management-Led Private Placement
-
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Silver Storm Reports Concentrate Deliveries from La Parrilla
-
Ispire Technology Inc. Reports First Quarter Fiscal Year 2027 Financial Results
-
HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
United States Antimony Corporation Announces Webcast Time set for Thursday, November 12, 2026 at 4:15 PM ET to Report on Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
-
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
-
Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC(R) in Israel
-
Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery
-
Shelfietech Launched New Retail Software Platform
-
A Holiday-Season Moment for Penny-Stock Followers and Microcap Visionaries as Elektros Moves Its EV Patent Forward
-
Dolphin Subsidiary 42West Drives Global Communications Behind Box Office Leaders Godzilla Minus Zero and Ramayana
-
Visterra Landscape Group Expands Into Arkansas With Strategic Investment In Little Rock Landscape
-
Santa Claus Has Come Early: Elektros Brings An Early-Christmas Spark To Its Patented EV Charging Vision
-
SMX Is Building a Verifiable Identity Layer for Fashion, From Cotton Fields to Luxury Resale
-
Gladstone Land Corporation Earnings Call and Webcast Information
-
The Metals Royalty Company to Host Corporate Update Webinar on November 16, 2026
-
Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
-
Eylsia Nicolas Launches Global "Wake Me Up" Franchise After Surpassing 100 Million Meta Views in One Week
-
BioLargo Targets Growing Industrial PFAS Market with MasterClass at International Water Conference
-
Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
-
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
-
iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury
-
Central Tokyo Apartment Rents Forecast to Rise 11% by 2030
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
Researchers can see which laboratory tested each lot and check the report with that lab before ordering, on the company's official site, pacificedgelabs.io.
SACRAMENTO, CA / ACCESS Newswire / November 9, 2026 / Pacific Edge Labs, a U.S. supplier of research peptides and laboratory research materials, today announced that its public certificate-of-analysis library now lists more than 120 original reports from two independent laboratories, Freedom Diagnostics and Vanguard Laboratory, including 44 reports from September 2026. Each listing shows the testing laboratory, the lab's own report ID and the report date. Reports from Freedom Diagnostics also open directly on the laboratory's own website.
"Researchers shouldn't have to take a supplier's word for purity," the Pacific Edge Labs quality team said. "Putting the lab's own record next to every report is the simplest way we know to earn that trust."
The library is at https://www.pacificedgelabs.io/test-results/. Every product page links its original reports, and the company's support team can confirm which lot is currently shipping.
Pacific Edge Labs also reminds researchers that pacificedgelabs.io is its only official store. Look-alike websites and pages that use the company's name are not affiliated with Pacific Edge Labs; the company's Official Websites page (https://www.pacificedgelabs.io/official-websites/) lists the sites it operates.
About Pacific Edge Labs
Pacific Edge Labs is a U.S.-based supplier of research peptides and laboratory research compounds for qualified researchers and professional laboratory environments. Products are sold for laboratory research use only. They are not intended for human or veterinary use and have not been evaluated by the U.S. Food and Drug Administration. Learn more at https://www.pacificedgelabs.io.
Media contact
Pacific Edge Labs quality team
[email protected]
+1 323-303-3891
SOURCE: Pacific Edge Labs LLC
View the original press release on ACCESS Newswire
P.Stevenson--AMWN